HVTN Translational HIV Vaccine Early Stage Investigator (ESI) Conference

September 12-13, 2022


To register for the conference, click here.
Registration Closes: August 10, 2022


The Nines Hotel, Portland Oregon

ESI Conference Overview

The HIV Vaccine Trials Network is proud to announce that it will host the 6th Translational HIV Vaccine Early Stage Investigator Conference, September 12-13, 2022, prior to the NHP AIDS Symposium. 

This conference is intended for ESIs who focus on translational HIV research in non-human primates (NHPs), or clinical HIV and TB research. Investigators participating in the conference will gain a sense of their ability to contribute widely to the field and obtain support in reaching career milestones. Past attendees have stated that the Conference has increased their skills and knowledge for career development and provided them with a venue to form new collaborations.

Target Audience

ESIs who focus on preclinical or clinical HIV vaccine research and are within ten (10) years of completing their terminal research degree (PhD, MD, DVM), medical residency, or equivalent.

Travel Award

The HVTN will offer a limited number of travel awards to attend this conference. The travel award application deadline is July 7, 2022.

Apply for Travel Award

COVID-19-related Policies (subject to change)

All in-person ESI Conference attendees (guests, speakers, staff) are required to provide proof of COVID-19 vaccination, wear a mask at all times, and complete a daily rapid test. Please click here for a full list of requirements.


The program for the 2022 Conference is under development. However, organizers plan to cover the following topics during the Conference:

  • Mucosal and innate immunity
  • Manuscript publication 
  • Grant writing 
  • ESI Works in Progress
  • Impact of new techniques and new technologies on TB
  • Opportunities for working with HVTN

NHP AIDS Symposium

The HVTN Translational ESI Conference will take place prior to the NHP AIDS Symposium, which is being held September 13-16, 2022, at the Nines Hotel, in Portland, OR. Participation in the NHP Symposium will provide attendees further opportunities to expand their knowledge of HIV vaccine science and to continue to develop professional networks.

Funding for this conference was made possible in part by 2R13OD024033 from the Office of the Director, National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the National Institutes of Health (NIH); nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Conference Contacts

For questions about the conference, please contact

Alex Berger
Project Coordinator